News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TransForm Pharmaceuticals, Inc. And University of South Florida Announce Collaboration To Improve Drug Performance Through Co-crystals


10/19/2005 5:11:06 PM

TransForm Pharmaceuticals, Inc. (TransForm) today announced a major collaborative effort with University of South Florida (USF) in Tampa, FL in the design and discovery of pharmaceutical co-crystal structures to enhance drug properties. Pharmaceutical co-crystals, a newly recognized category of small molecule pharmaceutical physical forms, can impact the physical-chemical properties of a drug by improving properties such as solubility, dissolution rate, stability and processing. A review of the field of pharmaceutical co-crystals entitled "Crystal Engineering of the Composition of Pharmaceutical Phases. Do Pharmaceutical Co-crystals Represent a New Path to Improved Medicines?" is currently available on-line at www.rsc.org and will appear in print in Chemical Communications, a publication of the Royal Society of Chemistry, in Issue 17 scheduled to publish on September 7, 2004.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES